As of 2025-03-23, the EV/EBITDA ratio of Mersana Therapeutics Inc (MRSN) is 0.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRSN's latest enterprise value is -31.23 mil USD. MRSN's TTM EBITDA according to its financial statements is -71.71 mil USD. Dividing these 2 quantities gives us the above MRSN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 13.1x | 12.0x |
| Forward P/E multiples | 17.4x - 34.9x | 21.8x |
| Fair Price | (9.31) - (6.87) | (9.05) |
| Upside | -2289.1% - -1715.6% | -2226.9% |
| Date | EV/EBITDA |